An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia

被引：3
|
作者：
Li, Xue-Ying [1 ,2 ,3 ]
Qian, Jie-Jing [1 ,2 ,3 ]
Yang, Min [1 ,2 ,3 ]
Zhang, Yi [1 ,2 ,3 ]
Wang, Sha-Sha [1 ,2 ,3 ]
Meng, Hai-Tao [1 ,2 ,3 ]
Yu, Wen-Juan [1 ,2 ,3 ]
Tong, Hong-Yan [1 ,2 ,3 ]
Ye, Xiu-Jin [1 ,2 ,3 ]
Jin, Jie [1 ,2 ,3 ]
Zhu, Hong-Hu [1 ,2 ,3 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Zhejiang Prov Key Lab Hematol Oncol Diag & Treatm, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 06期
基金：
中国国家自然科学基金;
关键词：
IMATINIB; PHASE-2;
D O I：
10.1111/bjh.16661
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E231 / E234
页数：4
相关论文
共 50 条
  • [21] Imatinib - In relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Cross, Sarah A.
    Lyseng-Williamson, Katherine A.
    DRUGS, 2007, 67 (17) : 2645 - 2654
  • [22] ImatinibIn Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
    Sarah A. Cross
    Katherine A. Lyseng-Williamson
    Drugs, 2007, 67 : 2645 - 2654
  • [23] A new face in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Kondo, Takeshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2131 - 2133
  • [24] Dasatinib - In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Keam, Susan J.
    BIODRUGS, 2008, 22 (01) : 59 - 69
  • [25] Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
    Faderl, S
    Kantarjian, HM
    Thomas, DA
    Cortes, J
    Giles, F
    Pierce, S
    Albitar, M
    Estrov, Z
    LEUKEMIA & LYMPHOMA, 2000, 36 (3-4) : 263 - 273
  • [26] Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
    Thomas, Xavier
    Dombret, Herve
    LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1246 - 1254
  • [27] Efficacy of Chemotherapy-Free Regimens in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
    Ali, Muhammad Ashar
    Aiman, Wajeeha
    Kantarjian, Hagop
    Jabbour, Elias
    Ravandi, Farhad
    Jain, Nitin
    Short, Nicholas J.
    Sasaki, Koji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10): : e376 - e384
  • [28] Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution
    Schwartz, Marc
    McMahon, Christine M.
    Amaya, Maria L.
    Witkowski, Matthew
    Pollyea, Daniel A.
    Gutman, Jonathan A.
    Minhajuddin, Mohd
    Smith, Clayton
    Jordan, Craig T.
    BLOOD, 2023, 142
  • [29] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
    Sasaki, Yuya
    Kantarjian, Hagop M.
    Short, Nicholas J.
    Wang, Feng
    Furudate, Ken
    Uryu, Hidetaka
    Garris, Rebecca
    Jain, Nitin
    Sasaki, Koji
    Ravandi, Farhad
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Little, Latasha
    Gumbs, Curtis
    Zhao, Li
    Futreal, P. Andrew
    Takahashi, Koichi
    Jabbour, Elias
    LEUKEMIA, 2022, 36 (05) : 1253 - 1260
  • [30] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
    Yuya Sasaki
    Hagop M. Kantarjian
    Nicholas J. Short
    Feng Wang
    Ken Furudate
    Hidetaka Uryu
    Rebecca Garris
    Nitin Jain
    Koji Sasaki
    Farhad Ravandi
    Marina Konopleva
    Guillermo Garcia-Manero
    Latasha Little
    Curtis Gumbs
    Li Zhao
    P. Andrew Futreal
    Koichi Takahashi
    Elias Jabbour
    Leukemia, 2022, 36 : 1253 - 1260
12345